Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Dyslipidemia

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 41 articles: HTML format

Single Articles

January 2025
1. LEWEK J, Sosnowska B, Starostecka E, Konopka A, et al
   Clinical reality and challenges with familial hypercholesterolemia patients' management. 2024 results from the Regional Center for Rare Diseases (RCRD) Registry in Poland.
   Int J Cardiol. 2025;419:132667.
   PubMed     Abstract available
   
   
   
2. CAHUAPAZA-GUTIERREZ NL, Calderon-Hernandez CC, Chambergo-Michilot D, De Arruda-Chaves E, et al
   Clinical characteristics, management, diagnostic findings, and various etiologies of patients with Kounis syndrome. A systematic review.
   Int J Cardiol. 2025;418:132606.
   PubMed     Abstract available
   
   
   October 2024
3. ATHAR M
   Potentials of artificial intelligence in familial hypercholesterolemia: Advances in screening, diagnosis, and risk stratification for early intervention and treatment.
   Int J Cardiol. 2024;412:132315.
   PubMed     Abstract available
   
   
   
4. ASTERIS PG, Gavriilaki E, Kampaktsis PN, Gandomi AH, et al
   Revealing the nature of cardiovascular disease using DERGA, a novel data ensemble refinement greedy algorithm.
   Int J Cardiol. 2024;412:132339.
   PubMed     Abstract available
   
   
   
5. GIACOBBE F, Bruno F, Brero M, Macaya F, et al
   Spontaneous coronary artery dissection (SCAD) with cardiac arrest at presentation: A subanalysis from the DISCO registry.
   Int J Cardiol. 2024;412:132331.
   PubMed     Abstract available
   
   
   September 2024
6. REGIS SC, Del Castillo-Rix D, Colombo R
   Patterns of coronary artery disease trends in patients with nephrotic syndrome: A national inpatient study.
   Int J Cardiol. 2024;410:132200.
   PubMed     Abstract available
   
   
   August 2024
7. FERNANDES-SILVA MM, Conti-Pelanda JD, Vosgerau LM, Cunha GSP, et al
   Temporal trends in the contribution of modifiable cardiovascular risk factors to cardiovascular and all-cause mortality in patients undergoing myocardial perfusion imaging in a large city in Brazil.
   Int J Cardiol. 2024;409:132178.
   PubMed     Abstract available
   
   
   July 2024
8. BOROVAC JA, D'Amario D, Miric D
   Management of dyslipidemia after atherosclerotic cardiovascular event: Still a long way to go...and we know it.
   Int J Cardiol. 2024;406:131967.
   PubMed    
   
   
   May 2024
9. HOE JK, Flege MM, Jimenez-Solem E, Hansen S, et al
   Monitoring and treatment of hypercholesterolemia after an atherosclerotic cardiovascular disease event in Denmark from 2015 to 2020.
   Int J Cardiol. 2024;402:131857.
   PubMed     Abstract available
   
   
   April 2024
10. ORTEGA-PAZ L, Bonaca M, Angiolillo DJ
    Optimizing LDL-cholesterol management in ACS patients: Breaking inertia and implementing intensified therapies.
    Int J Cardiol. 2024;400:131803.
    PubMed    
    
    
    March 2024
11. PINGITORE A, Zhang C, Vassalle C, Ferragina P, et al
    Machine learning to identify a composite indicator to predict cardiac death in ischemic heart disease.
    Int J Cardiol. 2024 Mar 23:131981. doi: 10.1016/j.ijcard.2024.131981.
    PubMed     Abstract available
    
    
    February 2024
12. KWAK S, Lee HJ, Lee H, Park JB, et al
    Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;396:131574.
    PubMed     Abstract available
    
    
    January 2024
13. CHERBI M, Bouisset F, Bonnefoy E, Lamblin N, et al
    Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
    Int J Cardiol. 2024;395:131578.
    PubMed     Abstract available
    
    
    December 2023
14. WU Y, Huang N, Sun T, Zhang B, et al
    Association between normalized lactate load and in-hospital mortality in patients with acute myocardial infarction.
    Int J Cardiol. 2023 Dec 23:131658. doi: 10.1016/j.ijcard.2023.131658.
    PubMed     Abstract available
    
    
    November 2023
15. SOLNICA B, Sniderman AD, Wyszomirski A, Rutkowski M, et al
    Concordance/discordance between serum apolipoprotein B, low density lipoprotein cholesterol and non-high density lipoprotein cholesterol in NATPOL 2011 participants - An epidemiological perspective.
    Int J Cardiol. 2023;390:131150.
    PubMed     Abstract available
    
    
    August 2023
16. GURGOGLIONE FL, Rizzello D, Giacalone R, Ferretti M, et al
    Precipitating factors in patients with spontaneous coronary artery dissection: Clinical, laboratoristic and prognostic implications.
    Int J Cardiol. 2023;385:1-7.
    PubMed     Abstract available
    
    
    May 2023
17. SHADAREVIAN J, Zhu K, Kwan JM, Wan D, et al
    Arrhythmic and thromboembolic outcomes in adults with coarctation of the aorta.
    Int J Cardiol. 2023 May 29:S0167-5273(23)00741.
    PubMed     Abstract available
    
    
    February 2023
18. D'ASCENZO F, Bruno F, Iannaccone M, Testa G, et al
    Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis.
    Int J Cardiol. 2023 Feb 28:S0167-5273(23)00256.
    PubMed     Abstract available
    
    
    
19. WEINTRAUB WS, Mancini GBJ, Boden WE
    Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond.
    Int J Cardiol. 2023;373:39-43.
    PubMed     Abstract available
    
    
    
20. PIERI K, Trichia E, Neville MJ, Taylor H, et al
    Polygenic risk in Type III hyperlipidaemia and risk of cardiovascular disease: An epidemiological study in UK Biobank and Oxford Biobank.
    Int J Cardiol. 2023;373:72-78.
    PubMed     Abstract available
    
    
    
21. NISHINO M, Egami Y, Kawanami S, Sugae H, et al
    Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
    PubMed     Abstract available
    
    
    
22. CAMPBELL-QUINTERO S, Echeverria LE, Gomez-Mesa JE, Rivera-Toquica A, et al
    Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00236.
    PubMed     Abstract available
    
    
    January 2023
23. AHMED AI, Al Rifai M, Alahdab F, Saad JM, et al
    Incremental prognostic value of digital positron emission tomography derived myocardial flow reserve: A prospective cohort study.
    Int J Cardiol. 2023;371:465-471.
    PubMed     Abstract available
    
    
    
24. PROENCA T, Pinto RA, Carvalho MM, Rocha A, et al
    Sex disparities and dyslipidemic control in a coronary rehabilitation program.
    Int J Cardiol. 2023;370:72-74.
    PubMed     Abstract available
    
    
    
25. ZANNONI J, Guazzi M, Milani V, Bandera F, et al
    Prognostic value of cardiopulmonary exercise testing in a European cohort with cardiovascular risk factors absent of a cardiovascular disease diagnosis.
    Int J Cardiol. 2023;370:402-404.
    PubMed     Abstract available
    
    
    November 2022
26. YOON YH, Park GM, Lee JY, Lee JH, et al
    Relationship between sexual differences and cardiovascular risk factors in the prevalence of asymptomatic coronary disease.
    Int J Cardiol. 2022 Nov 19:S0167-5273(22)01709.
    PubMed     Abstract available
    
    
    
27. ALMEIDA VR, Ostolin TLVDP, Gonze BB, de Almeida FR, et al
    Early flattening of the oxygen pulse during the cardiopulmonary exercise test in asymptomatic adults and its association with cardiovascular risk factors.
    Int J Cardiol. 2022;367:65-73.
    PubMed     Abstract available
    
    
    August 2022
28. MOHAMED MG, Osman M, Kheiri B, Saleem M, et al
    Polypill for cardiovascular disease prevention: Systematic review and meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022;360:91-98.
    PubMed     Abstract available
    
    
    July 2022
29. JAVAID A, Ahmed AI, Han Y, Al Rifai M, et al
    Incremental prognostic value of spect over CCTA.
    Int J Cardiol. 2022;358:120-127.
    PubMed     Abstract available
    
    
    April 2022
30. CIARDULLO S, Cannistraci R, Mazzetti S, Mortara A, et al
    Twenty-year trends in heart failure among U.S. adults, 1999-2018: The growing impact of obesity and diabetes.
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00578.
    PubMed     Abstract available
    
    
    
31. ORBAN M, Dietl M, Dischl D, von Samson-Himmelstjerna P, et al
    Assessment of sex- and age-dependency of risk factors for intimal hyperplasia in heart transplant patients using the high resolution of optical coherence tomography.
    Int J Cardiol. 2022 Apr 18. pii: S0167-5273(22)00556.
    PubMed     Abstract available
    
    
    
32. OH GC, Ko T, Kim JH, Lee MH, et al
    Estimation of low-density lipoprotein cholesterol levels using machine learning.
    Int J Cardiol. 2022;352:144-149.
    PubMed     Abstract available
    
    
    December 2021
33. RIZOS CV, Skoumas I, Rallidis L, Skalidis E, et al
    LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments.
    Int J Cardiol. 2021;345:119-124.
    PubMed     Abstract available
    
    
    October 2021
34. BOUISSET F, Deney A, Ferrieres J, Panagides V, et al
    Mechanical complications in ST-elevation myocardial infarction: The impact of pre-hospital delay.
    Int J Cardiol. 2021 Oct 23. pii: S0167-5273(21)01574.
    PubMed     Abstract available
    
    
    August 2021
35. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    PubMed     Abstract available
    
    
    May 2021
36. OTTOSSON F, Emami Khoonsari P, Gerl MJ, Simons K, et al
    A plasma lipid signature predicts incident coronary artery disease.
    Int J Cardiol. 2021;331:249-254.
    PubMed     Abstract available
    
    
    January 2021
37. NOURAEI H, Rabkin SW
    A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
    PubMed     Abstract available
    
    
    
38. HAN J, Bilgrami S, Ross S, Broadhead H, et al
    Real-world lipid lowering effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: A single-centre study.
    Int J Cardiol. 2021;322:240-244.
    PubMed    
    
    
    October 2020
39. ATHYROS VG, Stavropoulos K, Imprialos KP, Doumas M, et al
    Suboptimal management of dyslipidemia in everyday clinical practice: Alarming signals from real-world data.
    Int J Cardiol. 2020;316:240-241.
    PubMed    
    
    
    December 2019
40. STEWART LK, Beam DM, Casciani T, Cameron SJ, et al
    Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis.
    Int J Cardiol. 2019 Dec 26. pii: S0167-5273(19)30431.
    PubMed     Abstract available
    
    
    November 2019
41. BANDYOPADHYAY D, Chakraborty S, Amgai B, Patel N, et al
    Acute myocardial infarction in the young - National Trend Analysis with gender-based difference in outcomes.
    Int J Cardiol. 2019 Nov 12. pii: S0167-5273(19)33095.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.